bpc-157 safety human evidence review – No Proof Required! | Office for Science and Society BPC-157 and the Difference Between
Description
Bpc 157 treatment significantly reduced both plasma extravasation, histological alterations and alveolar bone resorption
Downstream effects via the active metabolite Pro-Gly-Pro, BDNF and NGF mRNA upregulation, and enkephalinase inhibition persist for 12 to 24 hours, which is why dosing frequency is set by downstream windows rather than plasma kinetics
An injection of vitamin B12 is more effective than using vitamins or relying on animal products
Treatment Group After treatment, there was a significant increase in total sulfate, and a large and marginally significant increase in free sulfate
